AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $42,694,000 | -17.9% | 925,121 | -1.9% | 0.03% | -16.7% |
Q2 2021 | $51,990,000 | +2.0% | 943,378 | -4.4% | 0.04% | -5.3% |
Q1 2021 | $50,978,000 | +19.2% | 987,188 | -0.0% | 0.04% | +15.2% |
Q4 2020 | $42,779,000 | +12.4% | 987,278 | -9.2% | 0.03% | 0.0% |
Q3 2020 | $38,055,000 | -34.6% | 1,087,278 | -0.0% | 0.03% | -37.7% |
Q2 2020 | $58,164,000 | +50.8% | 1,087,579 | +0.0% | 0.05% | +26.2% |
Q1 2020 | $38,580,000 | -25.4% | 1,087,379 | -0.0% | 0.04% | -2.3% |
Q4 2019 | $51,696,000 | +25.3% | 1,087,883 | -14.5% | 0.04% | +19.4% |
Q3 2019 | $41,242,000 | -44.5% | 1,272,905 | -14.5% | 0.04% | -43.8% |
Q2 2019 | $74,250,000 | -27.3% | 1,488,578 | -1.7% | 0.06% | -28.9% |
Q1 2019 | $102,149,000 | +47.3% | 1,514,658 | +0.7% | 0.09% | +28.6% |
Q4 2018 | $69,362,000 | -40.3% | 1,504,273 | -0.2% | 0.07% | -30.0% |
Q3 2018 | $116,194,000 | -8.4% | 1,506,662 | +0.0% | 0.10% | -3.8% |
Q2 2018 | $126,904,000 | +1.5% | 1,506,642 | -1.4% | 0.10% | -11.9% |
Q1 2018 | $124,993,000 | +43.0% | 1,528,408 | +0.0% | 0.12% | +45.7% |
Q4 2017 | $87,379,000 | -14.4% | 1,528,398 | -0.0% | 0.08% | -17.3% |
Q3 2017 | $102,054,000 | +29.3% | 1,528,895 | -0.3% | 0.10% | +25.6% |
Q2 2017 | $78,910,000 | -12.2% | 1,533,715 | -0.3% | 0.08% | -13.3% |
Q1 2017 | $89,872,000 | +40.0% | 1,538,912 | +0.0% | 0.09% | +26.8% |
Q4 2016 | $64,216,000 | -16.7% | 1,538,839 | +5.5% | 0.07% | -18.4% |
Q3 2016 | $77,051,000 | +25.9% | 1,458,751 | -0.1% | 0.09% | +20.8% |
Q2 2016 | $61,178,000 | +13.7% | 1,460,275 | +10.2% | 0.07% | +12.5% |
Q1 2016 | $53,783,000 | -37.0% | 1,324,699 | +0.7% | 0.06% | -35.4% |
Q4 2015 | $85,374,000 | +284.1% | 1,315,060 | +317.6% | 0.10% | +266.7% |
Q3 2015 | $22,227,000 | -27.2% | 314,878 | +14.6% | 0.03% | -15.6% |
Q2 2015 | $30,548,000 | +17.5% | 274,862 | -0.3% | 0.03% | +18.5% |
Q1 2015 | $26,004,000 | -15.9% | 275,763 | -0.1% | 0.03% | -18.2% |
Q4 2014 | $30,926,000 | +83.2% | 276,030 | +0.3% | 0.03% | +73.7% |
Q3 2014 | $16,877,000 | +33.9% | 275,100 | 0.0% | 0.02% | +35.7% |
Q2 2014 | $12,605,000 | +17.0% | 275,100 | 0.0% | 0.01% | +7.7% |
Q1 2014 | $10,770,000 | +65.7% | 275,100 | +1.4% | 0.01% | +62.5% |
Q4 2013 | $6,498,000 | +32.6% | 271,320 | +54.8% | 0.01% | +14.3% |
Q3 2013 | $4,899,000 | – | 175,220 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |